$14.82
Last update: Sep 28, 4:00 PM
Usana Health Sciences Inc
USNANYSE
Usana Health Sciences Earnings & Forecasts
Usana Health Sciences (USNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Usana Health Sciences Guidance
Usana Health Sciences (USNA) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $0.76 - $0.76, compared to a consensus EPS estimate of $2.12. Usana Health Sciences also guided revenue in the range of $910M - $910M for the period.
Compared to prior guidance, Usana Health Sciences lowered its EPS outlook from a previous range of $1.95 - $2.29. On the revenue side, the company lowered its revenue forecast from a prior range of $925M - $1B.
Usana Health Sciences has issued 21 guidance updates between October 25, 2022 and August 4, 2026. During this period, the company raised its outlook 4 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.43 | $0.44 | $0.41 | $-0.15 |
| Actual | $-0.07 | $0.61 | $0.60 | $-0.15 |
| Surprise | -116.3% | +38.6% | +46.3% | 0.00% |
| Revenue | ||||
| Estimate | $235.0M | $241.0M | $226.0M | $213.9M |
| Actual | $223.3M | $250.2M | $226.2M | $213.7M |
| Surprise | -4.99% | +3.83% | +0.11% | -0.10% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.11 | $0.11 | $0.34 | $0.46 |
| Revenue | ||||
| Consensus | $219.0M | $217.1M | — | — |
